Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6115b7f4561db088f26a575e9339fed0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc0a178b041dba3c38656de044d5d5f5 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4196 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-69 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4196 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-64 |
filingDate |
2010-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da1678c5ddc975e054f7a20c9a30cfd1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84e2e2d32079a32bcb78882a54f23f71 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ab1c147d6fc324fc0abdb18c37743f9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a93fc5232f63de8732c27e3f7a8d405 |
publicationDate |
2010-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2759187-A1 |
titleOfInvention |
Compositions for treatment of alzheimer's disease |
abstract |
The present invention includes A.beta.-reducing and/or A.beta.-anti-aggregation compounds and their uses in pharmaceuti-cal compositions. The present invention further includes methods of formulating pharmaceutical compositions and methods of ad-ministering the compositions for treatment of Alzheimer's disease. |
priorityDate |
2009-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |